Holds one active US DMF and 2 valid CEPs for mirtazapine, filing since 2023. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 20 markets.
Holds 6 active US DMFs and one valid CEP for mirtazapine, filing since 2002. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs and 2 valid CEPs for mirtazapine, filing since 2017. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for mirtazapine, filing since 2023. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds 2 active US DMFs and 2 valid CEPs for mirtazapine, filing since 2003. Its 2025 FDA inspection closed as VAI.
Holds 2 active US DMFs for mirtazapine, filing since 2007. Its 2023 FDA inspection closed as VAI.
Holds one active US DMF for mirtazapine, filing since 2006. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for mirtazapine, filing since 2024.
Registered with SFDA (Saudi Arabia) for mirtazapine. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 21 markets.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThis page filters the worldwide Mirtazapine manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free